drugset / Trial / NCT00490113
A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
Phase 2
Withdrawn
University of Kansas Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedCrossoverTriple-blindTreatment
Summary
To determine whether pyridoxamine can decrease oxalate excretion in subjects who have normal oxalate excretion (but who have had kidney stones), and in subjects who have primary hyperoxaluria.
Timeline
- Start
- 2007-01
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “Drug unavailable”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pyridorin | Unknown | 500 mg | — |
| Subject | Pyridorin | Unknown | 3500 mg | — |